## Abstract **Scope:** We investigated the inhibition of pulmonary tumor formation through treatment with curcumin in transgenic mice. **Methods and results:** In this study, a strain of transgenic mice carrying human vascular endothelial growth factor A~165~ (__hVEGFβA__~165~) gene to induce pulm
Overexpression of circulating vascular endothelial growth factor (VEGF) in leukocytoclastic vasculitis
β Scribed by J. Viac; I. Pernet; D. Schmitt; A. Claudy
- Publisher
- Springer-Verlag
- Year
- 1999
- Tongue
- English
- Weight
- 25 KB
- Volume
- 291
- Category
- Article
- ISSN
- 0340-3696
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background. Vascular endothelial growth factor (VEGF) is a specific endothelial cell mitogen that stimulates angiogenesis and plays a crucial role in tumor growth. The aim of the present study was to evaluate the expression of VEGF and of its two high-affinity tyrosine kinase receptors (KDR and Flt-
## Abstract Angiogenesis, the formation of new blood vessels, is controlled by a balance between positive and negative endothelial regulatory factors. Soluble vascular endothelial growth factor receptorβ1 (sVEGFR1), a naturally occurring soluble form of VEGFR1, is a negative counterpart of the vasc